BAMF
AZN icon

BI Asset Management Fondsmaeglerselskab’s AstraZeneca AZN Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-264,053
Closed -$45.1M – 624
2025
Q4 		$45.1M Sell
264,053
-74,744
-22% -$13.1M 0.4% 45
2025
Q3 		$48.7M Sell
338,797
-19,975
-6% -$3.02M 0.44% 47
2025
Q2 		$46.7M Buy
358,772
+61,429
+21% +$8.61M 0.46% 49
2025
Q1 		$43.7M Sell
297,343
-151,532
-34% -$21.9M 0.49% 38
2024
Q4 		$58.8M Buy
+448,875
New +$62.8M 0.62% 32
2024
Q3 		– Sell
-226,632
Closed -$35.4M – 607
2024
Q2 		$35.4M Buy
226,632
+19,940
+10% +$3M 0.58% 34
2024
Q1 		$28M Buy
206,692
+48,890
+31% +$6.47M 0.53% 48
2023
Q4 		$21.3M Buy
157,802
+2,412
+2% +$314K 0.45% 62
2023
Q3 		$21M Sell
155,390
-10,715
-6% -$1.46M 0.49% 55
2023
Q2 		$23.8M Sell
166,105
-22,701
-12% -$3.34M 0.56% 47
2023
Q1 		$26.2M Sell
188,806
-2,496
-1% -$336K 0.7% 41
2022
Q4 		$25.9M Sell
191,302
-12,314
-6% -$1.54M 0.69% 36
2022
Q3 		$22.3M Buy
203,616
+31,132
+18% +$3.95M 1.14% 20
2022
Q2 		$22.8M Sell
172,484
-16,898
-9% -$2.22M 0.97% 25
2022
Q1 		$25.1M Sell
189,382
-51
-0% -$6.12K 0.96% 24
2021
Q4 		$22.1M Buy
189,433
+9,272
+5% +$1.09M 0.81% 38
2021
Q3 		$21.6M Sell
180,161
-4,508
-2% -$525K 0.82% 33
2021
Q2 		$22.1M Sell
184,669
-14,739
-7% -$1.62M 0.85% 31
2021
Q1 		$19.8M Sell
199,408
-54,176
-21% -$5.45M 0.81% 35
2020
Q4 		$25.4M Buy
+253,584
New +$26.9M 1.1% 29

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

BI Asset Management Fondsmaeglerselskab's AZN Position: Q1 2026 in Review

BI Asset Management Fondsmaeglerselskab sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 264,053 shares — an estimated $45.1M sold.

BI Asset Management Fondsmaeglerselskab first reported a position in AZN in Q4 2020 and held it in 20 quarters. The position peaked at $58.8M in Q4 2024. 1,385 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • BI Asset Management Fondsmaeglerselskab reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 264,053 AstraZeneca shares in Q1 2026, an estimated $45.1M.
  • BI Asset Management Fondsmaeglerselskab first reported a position in AstraZeneca in Q4 2020 and held it in 20 quarters.
  • BI Asset Management Fondsmaeglerselskab's AstraZeneca position peaked at $58.8M in Q4 2024.
  • 1,385 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q1 2026, filed 16 Apr 2026.